Literature DB >> 16185273

Abnormal natural killer cell function in systemic sclerosis: altered cytokine production and defective killing activity.

Mayuka Horikawa1, Minoru Hasegawa, Kazuhiro Komura, Ikuko Hayakawa, Koichi Yanaba, Takashi Matsushita, Kazuhiko Takehara, Shinichi Sato.   

Abstract

Natural killer (NK) cells are innate immune effectors that produce various immunoregulatory cytokines. Recent studies have shown that NK cells are involved in the initiation of autoimmunity. In this study, we determined abnormalities of NK cells in systemic sclerosis (SSc), an autoimmune connective tissue disease, by assessing the frequency and absolute number, activation marker expression, cytokine production, and killing activity. The frequency and absolute number of NK cells increased in diffuse cutaneous SSc (dcSSc), whereas they were normal in limited cutaneous SSc (lcSSc). NK cells from both dcSSc and lcSSc patients exhibited activated phenotypes characterized by up-regulated CD16 and CD69 expression and downregulated CD62L expression. Interferon (IFN)-gamma production by non-stimulated NK cells from both dcSSc and lcSSc patients was increased compared to the normal control, whereas on stimulation, a reduced amount of IFN-gamma was produced. Interleukin (IL)-5 and IL-10 production by non-stimulated NK cells and IL-6 production by stimulated NK cells were augmented in dcSSc patients, but not in lcSSc patients. Despite the augmented cytokine production by non-stimulated NK cells, natural cytotoxicity activity and granzyme B secretion was reduced in NK cells from dcSSc and lcSSc patients. These results suggested that altered NK cell function contributes to immunological abnormalities in SSc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16185273     DOI: 10.1111/j.0022-202X.2005.23767.x

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  24 in total

Review 1.  Fibrogenesis, novel lessons from animal models.

Authors:  Ellen De Langhe; Rik Lories
Journal:  Semin Immunopathol       Date:  2015-07-04       Impact factor: 9.623

Review 2.  Cytokine Milieu in Undifferentiated Connective Tissue Disease: a Comprehensive Review.

Authors:  Britt Nakken; Edit Bodolay; Peter Szodoray
Journal:  Clin Rev Allergy Immunol       Date:  2015-10       Impact factor: 8.667

Review 3.  Coagulation and autoimmunity in scleroderma interstitial lung disease.

Authors:  Anna Ludwicka-Bradley; Richard M Silver; Galina S Bogatkevich
Journal:  Semin Arthritis Rheum       Date:  2010-12-17       Impact factor: 5.532

4.  NK cells influence both innate and adaptive immune responses after mucosal immunization with antigen and mucosal adjuvant.

Authors:  Lindsay J Hall; Simon Clare; Gordon Dougan
Journal:  J Immunol       Date:  2010-03-10       Impact factor: 5.422

5.  Contribution of HLA and KIR Alleles to Systemic Sclerosis Susceptibility and Immunological and Clinical Disease Subtypes.

Authors:  Aimee L Hanson; Joanne Sahhar; Gene-Siew Ngian; Janet Roddy; Jennifer Walker; Wendy Stevens; Mandana Nikpour; Shervin Assassi; Susanna Proudman; Maureen D Mayes; Tony J Kenna; Matthew A Brown
Journal:  Front Genet       Date:  2022-06-08       Impact factor: 4.772

6.  A mouse model links asthma susceptibility to prenatal exposure to diesel exhaust.

Authors:  Sarah Manners; Rafeul Alam; David A Schwartz; Magdalena M Gorska
Journal:  J Allergy Clin Immunol       Date:  2013-12-22       Impact factor: 10.793

Review 7.  Non-Hodgkin's lymphoma in systemic sclerosis: case and literature review.

Authors:  Serena Vettori; Stefania Staibano; Massimo Mascolo; Gennaro Ilardi; Gabriele Valentini
Journal:  Clin Rheumatol       Date:  2009-10-07       Impact factor: 2.980

Review 8.  T and NK Cell Phenotypic Abnormalities in Systemic Sclerosis: a Cohort Study and a Comprehensive Literature Review.

Authors:  Isabel Almeida; Sara Vieira Silva; Ana Raquel Fonseca; Ivone Silva; Carlos Vasconcelos; Margarida Lima
Journal:  Clin Rev Allergy Immunol       Date:  2015-12       Impact factor: 8.667

9.  Apoptosis modulation as a promising target for treatment of systemic sclerosis.

Authors:  Stéphane Chabaud; Véronique J Moulin
Journal:  Int J Rheumatol       Date:  2011-09-06

Review 10.  Selected Aspects in the Pathogenesis of Autoimmune Diseases.

Authors:  György Nagy; Peter C Huszthy; Even Fossum; Yrjö Konttinen; Britt Nakken; Peter Szodoray
Journal:  Mediators Inflamm       Date:  2015-08-02       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.